Shorts

1:21
RECAP: Neurology News Network - Week of August 8th
3 months ago
by
Louie Pasculli

1:03
What Advantages Does THUNDERBOLT Offer? | Part 2
3 months ago
by
Young Lee, MD(+1 more)

1:06
The Gut-Brain Connection in Parkinson Disease
3 months ago
by
Laurie Sanders, PhD(+1 more)

2:07
Future Genetic Therapies Poised to Shape PNS 2027
3 months ago
by
Brian Callaghan, MD, MS

1:07
What Advantages Does THUNDERBOLT Offer? | Part 1
3 months ago
by
Young Lee, MD(+1 more)

0:42
Why Nerve Pain Lingers After Injury
3 months ago
by
Mitzi Joi Williams, MD

1:29
Key Factors Driving Treatment Selection in Generalized Myasthenia Gravis
3 months ago
by
Miriam Freimer, MD(+1 more)

1:45
RECAP: Neurology News Network - Week of August 1st
3 months ago
by
Louie Pasculli

1:29
Navigating Drug Selection and Combination Therapy in gMG
4 months ago
by
Miriam Freimer, MD(+1 more)

1:09
Understanding Nerve Pain vs. Joint Pain
4 months ago
by
Mitzi Joi Williams, MD

1:26
AAIC 2026: Trontinemab and the Brainshuttle Technology
4 months ago
by
Geoff Kerchner, MD, PhD(+1 more)

1:08
CMSC 2026: Assessing Biological Disease Activity in MS
4 months ago
by
Darin T. Okuda, MD, FAAN, FANA(+1 more)

1:26
AAIC 2026: Future of Blood-Based Biomarkers for Alzheimer Care
4 months ago
by
Soeren Mattke, MD, DSc(+1 more)

0:55
AAIC 2026: Improving Amyloid Biomarker–Guided Diagnosis in AD
4 months ago
by
Suzanne Schindler, MD, PhD(+1 more)

2:02
RECAP: Neurology News Network - Week of July 25th
4 months ago
by
Louie Pasculli

0:35
Personalizing Communication About Emerging Alzheimer Disease Therapies
4 months ago
by
Betty Tijms, PhD(+1 more)

1:07
Fragile X Syndrome Day 2026: 3 Primary Domains of Symptoms
4 months ago
by
Craig A. Erickson, MD(+1 more)

0:47
World Brain Day 2026: What is the Best Way to Preserve and Maintain Brain Health?
4 months ago
by
Jason A. Cohen, MD(+1 more)

0:44
AAIC 2026: Why Every “Shot on Goal” Matters in Alzheimer Disease Care
4 months ago
by
Louie Pasculli(+1 more)

1:41
SLEEP 2026: Designing Phase 3 Trials for Narcolepsy Type 1
4 months ago
by
Elena Koundourakis, PhD(+1 more)

1:13
SLEEP 2026: Unmet Needs in Pediatric Sleep Medicine
4 months ago
by
Carol Rosen, MD(+1 more)

0:41
AAIC 2026: Where Can Patients Learn About Emerging Alzheimer Disease Therapies?
4 months ago
by
Jeff Dage, PhD(+1 more)

0:58
SLEEP 2026: New Guidance on RLS Management
4 months ago
by
Michael Silber, MBChB(+1 more)

0:53
Symptom Overlap Between Multiple Sclerosis and NMOSD
4 months ago
by
Mitzi Joi Williams, MD

0:50
CMSC 2026: Questioning Targets in MS Treatment
4 months ago
by
Ahmed Obeidat, MD, PhD(+1 more)

1:15
CMSC 2026: Enhancing MS Clinical Trial Impact
4 months ago
by
Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC(+1 more)

0:40
AAIC 2026: Rethinking Patient-Centered Neurology Care Today
4 months ago
by
Mirnova Ceide, MD, MS(+1 more)

0:40
Expanding the Approach to AD Care Beyond Pharmacological Treatments
4 months ago
by
Elizabeth Rhodus, PhD, MS(+1 more)

0:58
RECAP: Neurology News Network - July 12th
4 months ago
by
Louie Pasculli

0:40
AAIC 2026: Characterizing Midlife Brain Health in Retired Soccer Players
4 months ago
by
Caleigh G. Lynch, MSc(+1 more)
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
